HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

6-(Methylsulfonyl) Hexyl Isothiocyanate: A Chemopreventive Agent Inducing Autophagy in Leukemia Cell Lines.

Abstract
Autophagy is a fundamental catabolic process of cellular survival. The role of autophagy in cancer is highly complex: in the early stages of neoplastic transformation, it can act as a tumor suppressor avoiding the accumulation of proteins, damaged organelles, and reactive oxygen species (ROS), while during the advanced stages of cancer, autophagy is exploited by cancer cells to survive under starvation. 6-(Methylsulfonyl) hexyl isothiocyanate (6-MITC) is the most interesting compound in the Wasabia Japonica rizhome. Recently, we proved its ability to induce cytotoxic, cytostatic, and cell differentiation effects on leukemic cell lines and its antimutagenic activity on TK6 cells. In the current study, to further define its chemopreventive profile, Jurkat and HL-60 cells were treated with 6-MITC for 24 h. The modulation of the autophagic process and the involvement of ROS levels as a possible trigger mechanisms were analyzed by flow cytometry. We found that 6-MITC induced autophagy in Jurkat and HL-60 cells at the highest concentration tested and increased ROS intracellular levels in a dose-dependent manner. Our results implement available data to support 6-MITC as an attractive potential chemopreventive agent.
AuthorsVeronica Cocchi, Beatriz Jávega, Sofia Gasperini, José-Enrique O'Connor, Monia Lenzi, Patrizia Hrelia
JournalBiomolecules (Biomolecules) Vol. 12 Issue 10 (Oct 14 2022) ISSN: 2218-273X [Electronic] Switzerland
PMID36291694 (Publication Type: Journal Article)
Chemical References
  • 6-(Methylsulfinyl)hexyl isothiocyanate
  • Reactive Oxygen Species
  • Cytostatic Agents
  • isothiocyanic acid
  • Isothiocyanates
Topics
  • Humans
  • Reactive Oxygen Species
  • Cytostatic Agents (pharmacology)
  • Isothiocyanates (pharmacology)
  • Leukemia (drug therapy)
  • Autophagy
  • HL-60 Cells
  • Apoptosis
  • Cell Line, Tumor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: